These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
166 related items for PubMed ID: 36655863
1. Diarrhoea-associated haemolytic uraemic syndrome and Shiga toxin-producing Escherichia coli infections in New Zealand children: Clinical features and short-term complications from a 23-year cohort study. Wong W, Prestidge C, Dickens A, Ronaldson J. J Paediatr Child Health; 2023 Mar; 59(3):493-498. PubMed ID: 36655863 [Abstract] [Full Text] [Related]
2. Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008. Jenssen GR, Vold L, Hovland E, Bangstad HJ, Nygård K, Bjerre A. BMC Infect Dis; 2016 Jun 13; 16():285. PubMed ID: 27297224 [Abstract] [Full Text] [Related]
3. Paediatric haemolytic uraemic syndrome related to Shiga toxin-producing Escherichia coli, an overview of 10 years of surveillance in France, 2007 to 2016. Bruyand M, Mariani-Kurkdjian P, Le Hello S, King LA, Van Cauteren D, Lefevre S, Gouali M, Jourdan-da Silva N, Mailles A, Donguy MP, Loukiadis E, Sergentet-Thevenot D, Loirat C, Bonacorsi S, Weill FX, De Valk H, Réseau français hospitalier de surveillance du SHU pédiatriqueMembers of the Réseau français hospitalier de surveillance du SHU pédiatrique have been listed at the end of the article.. Euro Surveill; 2019 Feb 13; 24(8):. PubMed ID: 30808442 [Abstract] [Full Text] [Related]
8. Estimating true incidence of O157 and non-O157 Shiga toxin-producing Escherichia coli illness in Germany based on notification data of haemolytic uraemic syndrome. Kuehne A, Bouwknegt M, Havelaar A, Gilsdorf A, Hoyer P, Stark K, Werber D, HUS active surveillance network Germany. Epidemiol Infect; 2016 Nov 05; 144(15):3305-3315. PubMed ID: 27468812 [Abstract] [Full Text] [Related]
9. [Post-diarrheal haemolytic uremic syndrome: when shall we consider it? Which follow-up?]. Bertholet-Thomas A, Ranchin B, King LA, Bacchetta J, Belot A, Gillet Y, Collardeau-Frachon S, Cochat P. Arch Pediatr; 2011 Jul 05; 18(7):823-30. PubMed ID: 21571510 [Abstract] [Full Text] [Related]